Ledger.Open graph →
SEC Form D · Amendment · filed February 27, 2019

Tempest Therapeutics, Inc

Offering
$70.2M
Sold
$48.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Thomas J. Woiwode · San Francisco, CADirectorThomas W. Dubensky, Jr · San Francisco, CAExec · DirectorRobert J. Weisskoff · San Francisco, CADirectorPetpiboon J. Prasit · San Francisco, CADirectorBradley J. Bolzon · San Francisco, CADirectorStella J. Xu · San Francisco, CADirectorMichael J. Raab · San Francisco, CADirectorMary Ann Tyszko · Syracuse, NYDirectorPeter Cohen · Syracuse, NYDirectorIra Fedder · Syracuse, NYExec · DirectorBryan Greene · Syracuse, NYDirectorAndrew Rock · Syracuse, NYDirectorJeremy Williams · Syracuse, NYDirectorIvan Markman · CULVER CITY, CADirectorSteven Hamerslag · CULVER CITY, CADirectorJeffrey Pressman · CULVER CITY, CADirectorIgor Vaks · CULVER CITY, CAExec · DirectorDaniel Murray · CULVER CITY, CADirectorNL Series Genpar LLC · Ft. Worth, TXDirectorMichael J. Raab · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗